| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |